SPC
BMEZ icon

Spirepoint Private Client’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Spirepoint Private Client’s Portfolio BMEZ Stock Details BMEZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$150K Buy
10,436
+197
+2% +$2.93K 0.01% 317
2025
Q4 		$154K Buy
+10,239
New +$154K 0.01% 306

Other funds holding BMEZ

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Spirepoint Private Client's BMEZ Position: Q1 2026 in Review

Spirepoint Private Client increased its BlackRock Health Sciences Trust II (BMEZ) stake by 1.9% in Q1 2026, buying an estimated $2.93K and bringing the position to 10,436 shares worth $150K. The position accounts for 0.01% of the portfolio, ranked #317.

Spirepoint Private Client first reported a position in BMEZ in Q4 2025 and has held it in 2 quarters since. The position peaked at $154K in Q4 2025. 88 funds tracked by Wall St. Rank hold BMEZ as of Q1 2026.

  • Spirepoint Private Client held 10,436 shares of BlackRock Health Sciences Trust II worth $150K as of Q1 2026.
  • Spirepoint Private Client bought 197 BlackRock Health Sciences Trust II shares in Q1 2026, an estimated $2.93K.
  • BlackRock Health Sciences Trust II made up 0.01% of Spirepoint Private Client's portfolio in Q1 2026, its #317 holding.
  • Spirepoint Private Client first reported a position in BlackRock Health Sciences Trust II in Q4 2025 and has held it in 2 quarters since.
  • Spirepoint Private Client's BlackRock Health Sciences Trust II position peaked at $154K in Q4 2025.
  • 88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2026.

Based on Spirepoint Private Client's 13F filing for Q1 2026, filed 22 Apr 2026.